Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Methylergonovine maleate bulk supplier for pharma manufacturers

Methylergonovine Maleate 0.2 mg, 0.2 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Tablet / Injection

Available Strengths: 0.2 mg, 0.2 mg/mL

Reference Brands: Methergine (USA)

Category: Women's Health

Methylergonovine is a semisynthetic ergot alkaloid that acts as a strong uterotonic — it stimulates uterine muscle contraction to reduce bleeding after childbirth. It is used by obstetricians and in maternity care settings to prevent or treat postpartum hemorrhage. Common effects may include increased blood pressure, nausea, headache, and uterine cramps; monitoring is important during use.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Methylergonovine Maleate — third party manufacturing & bulk supply

Methylergonovine Maleate 0.2 mg, 0.2 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Methylergonovine Maleate is supplied as Tablet / Injection — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Methylergonovine Maleate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Methylergonovine Maleate →
Back to Listing

Frequently Asked Questions

Methylergonovine is used to prevent and treat excessive bleeding after childbirth (postpartum hemorrhage) by strengthening and promoting uterine muscle contractions.

Methylergonovine is the active molecule methylergonovine maleate — a semisynthetic ergot derivative that acts as a uterotonic on smooth uterine muscle.

The main trade name commercially used is Methergine.

Methergine and its generic equivalents are manufactured by various pharmaceutical companies globally; brand ownership may differ by region.

The generic name is methylergonovine maleate.

The primary brand name is Methergine.

Methylergonovine is manufactured by licensed pharmaceutical producers in multiple countries, often under regional regulatory approval, depending on brand and generic distribution.

Related Products

Methyltestosterone

Strength:
10 mg

Form: Tablets

Reference Brands: Testred (USA/EU), Methitest (USA/EU)

View Details
Metyrapone

Strength:
250 mg

Form: Tablets

Reference Brands: Metopirone (USA/EU)

View Details
Mifepristone

Strength:
200 mg, 300 mg

Form: Tablets

Reference Brands: Mifeprex (USA), Mifegyne (EU)

View Details
Menotropins

Strength:
75 IU, 150 IU

Form: Injection

Reference Brands: Menopur (USA/EU), Repronex (USA/EU)

View Details
Progesterone 8% Gel

Strength:
8% w/w

Form: Vaginal Gel

Reference Brands: Prochieve(EU)

View Details
Urofollitropin Injection

Strength:
75 IU

Form: Injection

Reference Brands: Gonal-f (US/EU)

View Details
Gonadotropin Injection

Strength:
10000 IU

Form: Injection

Reference Brands:

View Details
Gonadotropin Injection

Strength:
20000 IU

Form: Injection

Reference Brands:

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.